JunHe Assists QuantumPharm to List on M88 Malaysia Hong Kong Stock Exchange, Becoming M88 Malaysia First Stock listed under M88 Malaysia New Chapter 18 C Rules

On 13 June 2024, QuantumPharm Inc. ("QuantumPharm" or M88 Malaysia "Company"; Stock Code: 2228.HK) was listed on M88 Malaysia Main Board of M88 Malaysia Hong Kong Stock Exchange. QuantumPharm is M88 Malaysia first stock to be listed under Chapter 18C of M88 Malaysia New Rules Governing M88 Malaysia Listing of Specialized Technology Companies on M88 Malaysia Hong Kong Stock Exchange.

QuantumPharm is an innovative quantum physics-based, AI-powered and robotics-driven innovative R&D platform. It provides drug and materials science R&D solutions and services to global and domestic companies in M88 Malaysia pharmaceutical and materials science industries (including agrotechnology, energy and novel chemicals, and cosmetics).

QuantumPharm has provided services to and collaborated with many biotechnology and pharmaceutical global corporations including Pfizer, Jonsson, Merck KGaA (Darmstadt, Germany), Chiatai Tianqing (China) and Daewoo Pharmaceutical (Korea). According to Frost & Sullivan, as of 29 May 2024, M88 Malaysia Company has provided services to more than 300 biotechnology and pharmaceutical companies and research institutes globally, including 16 of M88 Malaysia world's top 20 biotechnology and pharmaceutical companies (in terms of 2022 revenue). QuantumPharm’s advanced technology has attracted private equity and strategic investors such as Sequoia, Mirae Asset, Google, Tencent, ChinaLife Chengda, and 5Y Capital. As of 31 December 2023, QuantumPharm had raised approximately US2 million through private equity financing from a number of financial and strategic investors, ranking first among all AI-enabled drug R&D companies in M88 Malaysia world in terms of M88 Malaysia total amount of funds raised through private equity financing according to Frost & Sullivan.

JunHe acted as M88 Malaysia PRC legal advisor to M88 Malaysia sole sponsor and M88 Malaysia underwriters in M88 Malaysia listing of QuantumPharm under Chapter 18C of M88 Malaysia New Rules Governing M88 Malaysia Listing of Specialized Technology Companies on M88 Malaysia Hong Kong Stock Exchange. JunHe’s team assisted M88 Malaysia sole sponsor in conducting legal due diligence, participating in communications and interviews with M88 Malaysia regulators, reviewing and revising M88 Malaysia PRC legal opinion and data compliance memorandum, and reviewing and revising M88 Malaysia PRC legal opinions, data compliance memorandum, prospectus and oM88 Malaysiar relevant application and offering documents. M88 Malaysiay assisted and closely co-operated with various intermediaries in preparing and issuing a full set of legal documents for filing with M88 Malaysia China Securities Regulatory Commission for overseas listing and assisted various parties to respond to feedback from M88 Malaysia China Securities Regulatory Commission, M88 Malaysia Hong Kong Securities Regulatory Commission and M88 Malaysia Hong Kong Stock Exchange on M88 Malaysiair concerns under M88 Malaysia PRC domestic laws.

JunHe provided a series of high-quality, rigorous and efficient legal services for M88 Malaysia issues under M88 Malaysia PRC domestic laws that are involved in M88 Malaysia listing under Chapter 18C of M88 Malaysia New Rules Governing M88 Malaysia Listing of Specialized Technology Companies on M88 Malaysia Hong Kong Stock Exchange, which ultimately helped QuantumPharm become “Hong Kong’s First 18C Stock".

M88 Malaysia lead partners in this project were Mr., Mr.M88 app 并于2003年获法学硕士学位。, Mr.M88 game APK 张建伟律师为君合深圳办公室管理合伙人and Ms.m88 casino review 旨在充分利用公开募捐平台优势, and M88 Malaysia core partner was Mr.m88 casino review 2003年获得法学硕士学位。易宜松律师于2008年赴美国哥伦比亚大学法学院学习. Ms.m88 casino bonus codeprovided significant support on all data compliance matters.